Robust Approaches to Advance Pre-Filled Syringe Development

Douglas Cusato from Sumitomo Rubber Industries will be speaking next month at The 6th annual Pre-Filled Syringes East Coast Conference in Boston, where he will discuss the current issues surrounding Pre-Filled Syringe Development, such as reducing patient risk with elastomeric components, minimizing design verification failures and ensuring product robustness. Ahead of the conference, SMi Conferences interviewed him where he gave a taster of what he will be discussing.

Douglas said:

“The areas of development within the PFS space are fuelled by the strategy of the overall pharmaceutical market including personalized medicines, capturing and using health information and increased access to lower cost drugs. The implementation of these strategies require the industry to take a more holistic view and ensure product and service innovations align with future needs of the pharmaceutical market starting from early stage development through commercialization and life cycle management.”

“The impact of the personalized medicine strategy has required the PFS market to focus on various areas including overall supply chain / logistics and product quality.  Within the last year, the market has released various innovative technologies and optimized existing technologies to support improved product confidence via product quality specifications… “

The full interview is available in the Download Centre at www.pfsamericas.com/pr6

Key sessions on Day Two of the Conference include:

  • PFS / autoinjector compatibility – impacts to manufacturing and drug delivery performance
  • Design the container around the device – benefits of primary container customization with cyclic olefin copolymers for large volume injectors
  • Challenges in developing high concentration formulations for combination products
  • Effects of aging and transportation of pre-filled syringes on device performance
  • Design device strategy for successful implementation of connected devices

Speakers include:

Joyce Y Zhao, Device Lead, Combination Product Development, Takeda
Patrick Gallagher, Head of Business Development – Polymer Solutions, SCHOTT AG
Ramin Samadani, Senior Scientist in Dosage, Form, Design and Development, MedImmune
Brian Frank Lewis, Senior Consultant Engineer, Eli Lilly
Cedric Gysel, Health Care Solutions Design Manager, Johnson & Johnson Design

Sponsored by:
3P Innovation | Aptar Pharma | CSS (CONNECTICUT SPRING & STAMPING) | Harro Höfliger | LONSTROFF | MITSUBISHI GAS CHEMICAL | NN Life Sciences | Owen Mumford | Polyplastics | RheoSense | SCHOTT | Steri-Tek | SUMITOMO RUBBER INDUSTRIES | West Pharmaceutical Services | ZEON |

Contacts:
Sponsorship, exhibition and branding packages: Alia Malick +44 (0)20 7827 6168 / amalick@smi-online.co.uk
Delegate enquiries: Kieran Ronaldson on +44 (0) 20 7827 6744 / kronadlson@smi-online.co.uk

Media enquiries contact Neill Howard +44 (0) 207 827 6164 nhoward@smi-online.co.uk
————————————————————————————

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Leave A Reply

Your email address will not be published.